These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17488690)
1. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Aessopos A; Kati M; Farmakis D Haematologica; 2007 May; 92(5):658-65. PubMed ID: 17488690 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in beta-thalassemia. Aessopos A; Farmakis D Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682 [TBL] [Abstract][Full Text] [Related]
10. Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management. Aessopos A; Berdoukas V Mediterr J Hematol Infect Dis; 2009 Jul; 1(1):e2009002. PubMed ID: 21415984 [TBL] [Abstract][Full Text] [Related]
11. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680 [TBL] [Abstract][Full Text] [Related]
12. Cardiac involvement in beta-thalassaemia: current treatment strategies. Paul A; Thomson VS; Refat M; Al-Rawahi B; Taher A; Nadar SK Postgrad Med; 2019 May; 131(4):261-267. PubMed ID: 31002266 [TBL] [Abstract][Full Text] [Related]
13. Detection of the cardiovascular complications of thalassemia by echocardiography. Walker JM; Nair S Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia. Aessopos A; Stamatelos G; Skoumas V; Vassilopoulos G; Mantzourani M; Loukopoulos D Chest; 1995 Jan; 107(1):50-3. PubMed ID: 7813310 [TBL] [Abstract][Full Text] [Related]
16. β-thalassemia intermedia: a clinical perspective. Musallam KM; Taher AT; Rachmilewitz EA Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a013482. PubMed ID: 22762026 [TBL] [Abstract][Full Text] [Related]
17. Better survival and less cardiac morbidity in female patients with thalassemia major: a review of the literature. Marsella M; Pepe A; Borgna-Pignatti C Ann N Y Acad Sci; 2010 Aug; 1202():129-33. PubMed ID: 20712783 [TBL] [Abstract][Full Text] [Related]
18. Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis. Stoyanova E; Cloutier G; Felfly H; Lemsaddek W; Ah-Son N; Trudel M PLoS One; 2012; 7(12):e52128. PubMed ID: 23284899 [TBL] [Abstract][Full Text] [Related]
19. Iron overload in β-thalassemia intermedia: an emerging concern. Musallam KM; Cappellini MD; Taher AT Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199 [TBL] [Abstract][Full Text] [Related]
20. The correlation between cardiac magnetic resonance T2* and left ventricular global longitudinal strain in people with β-thalassemia. Parsaee M; Akiash N; Azarkeivan A; Alizadeh Sani Z; Amin A; Pazoki M; Samiei N; Jalili MA; Adel MH; Rezaian N Echocardiography; 2018 Apr; 35(4):438-444. PubMed ID: 29399871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]